The PE Ratio as of November 2024 (TTM) for iCAD, Inc. (ICAD) is -10.87

According to iCAD, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.87. This represents a change of 205.25% compared to the average of -3.56 of the last 4 quarters.

iCAD, Inc. (ICAD) Historical PE Ratio (quarterly & annually)

How has ICAD PE Ratio performed in the past?

The mean historical PE Ratio of iCAD, Inc. over the last ten years is -19.90. The current -10.87 PE Ratio has changed 5.36% with respect to the historical average. Over the past ten years (40 quarters), ICAD's PE Ratio was at its highest in in the September 2014 quarter at 137.35. The PE Ratio was at its lowest in in the December 2014 quarter at -371.12.

iCAD, Inc. (ICAD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of iCAD, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iCAD, Inc. (ICAD) Average PE Ratio

How has ICAD PE Ratio performed in the past?

The current PE Ratio of iCAD, Inc. (ICAD) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

iCAD, Inc. (ICAD) PE Ratio vs. Peers

How is ICAD’s PE Ratio compared to its peers?

iCAD, Inc.’s PE Ratio is less than Profound Medical Corp. (-7.21), greater than SI-BONE, Inc. (-13.79), less than Sight Sciences, Inc. (-4.44), less than Nevro Corp. (-2.55), less than Paragon 28, Inc. (-8.85), less than STRATA Skin Sciences, Inc. (-1.28), less than Sientra, Inc. (-0.03), greater than AxoGen, Inc. (-37.53), less than Ainos, Inc. (-0.19), less than LENSAR, Inc. (-5.34), less than Aziyo Biologics, Inc. (-0.75), less than INVO Bioscience, Inc. (-0.42), less than enVVeno Medical Corporation (-2.56), greater than Establishment Labs Holdings Inc. (-15.68), less than CVRx, Inc. (-5.63), less than Surgalign Holdings, Inc. (-0.05), greater than Surmodics, Inc. (-380.53), less than Biomerica, Inc. (-0.97), greater than Movano Inc. (-14.54),

Build a custom stock screener for iCAD, Inc. (ICAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iCAD, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iCAD, Inc. (ICAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iCAD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.